DOCSLIB.ORG

Human Artificial Chromosomes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Gene Therapy (2009) 16, 1180–1188 & 2009 Macmillan Publishers Limited All rights reserved 0969-7128/09 $32.00 www.nature.com/gt REVIEW Progress and prospects: human artificial chromosomes S Macnab1,2 and A Whitehouse1,2 1Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK and 2Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK Artificial chromosomes (ACs) are highly promising vectors technically challenging to construct and diffcult to deliver to for use in gene therapy applications. They are able to maintain target cells. This review focuses on the current progress in the expression of genomic-sized exogenous transgenes within field of ACs and discusses the recent advances in purification, target cells, without integrating into the host genome. Although construction, delivery and potential new molecular therapies. these vectors have huge potential and benefits when compared Gene Therapy (2009) 16, 1180–1188; doi:10.1038/gt.2009.102; against normal expression constructs, they are highly complex, published online 27 August 2009 In brief Progress Propects Advances in the purification of YACs. Improvements to HAC and YAC purification proto- A new transposon-based technique for the generation cols. of novel virus-based BACs. Development of new or improved HAC and YAC Amplicon virus-like particles present efficient deliv- transduction methods for in vivo delivery will be ery mechanisms for ACs. developed. Hybrid AC technologies take advantage of the best Removal of contaminating virus from high titre traits of different vectors. amplicon delivery systems. AYAC-based method for genomic vector construction Use of genomic transcripts is viable and will reduce using TAR cloning. the need for cDNA transgenes. A novel method for BAC transgene molecular Further developments combining artificial chromo- tagging. somes and stem-cell therapeutics. BAC construct size may not affect in vivo vector The use of artificial chromosomes to treat a wide delivery. range of genetic diseases. Advances using ACs to deliver a wide variety of transgenes including CFTR, FRDA and dystrophin. ACs and stem-cell-based therapies. Keywords: HACs; BACs; YACs; amplicons; genomic transgenes; stem cells Introduction headings of human artificial chromosomes (HACs), bacterial artificial chromosomes (BACs), yeast artificial Artificial chromosomes (ACs) are promising tools for chromosomes (YACs) and P1-derived artificial chromo- gene therapy applications and possess many advantages somes (PACs).1,2 over current vector systems. Similar to endogenous The major advantages of ACs are their potential to chromosomes, ACs can replicate and segregate autono- overcome problems in gene therapy protocols such mously without integration into the host chromosome. as immunogenicity, insertional mutagenesis, oncogene There are a number of artificial chromosomal systems activation or limitations in capacity for transgene currently under development, which fall under the broad expression. Whether the AC is an HAC, BAC, YAC or PAC, the basic requirement for an AC remains the same; the AC needs to be independently transferred to progeny Correspondence: Dr A Whitehouse, Institute of Molecular and cells in a dividing cell population, although continuing Cellular Biology, Faculty of Biological Sciences, University of Leeds, to maintain spatial and temporal levels of long-term Leeds, LS2 9JT, UK. 3 E-mail: [email protected] transgene expression in specific cell types. In addition, Received 30 January 2009; revised 25 July 2009; accepted 28 July the AC should present no risk of cellular transformation 2009; published online 27 August 2009 or adverse immune system stimulation. Human artificial chromosomes S Macnab and A Whitehouse 1181 ACs can broadly be classified into two groups: linear 250 kb in size. An advantage of this methodology is that ACs and circular ACs. If a linear form of AC is used, it it is quicker than the pulse-field gel electrophoresis requires a number of cis-acting elements for successful purification method. In addition, it does not require the maintenance in vivo: (i) specific origins of replication, to use of time consuming CsCL-EthBr gradients of other maintain faithful DNA replication; (ii) a centromere, large DNA purification protocols. However, this system used for maintaining stability during the cell cycle and allows for the production and purification of vectors mitotic segregation and (iii) DNA capping telomeres, to containing genomic regions that are potentially unstable maintain linearity.4 Linear ACs have a potential for in standard Escherichia coli vectors. This technique is, unlimited transgene capacity. therefore, important as it may be suitable for carrying out Circular ACs are vectors generally produced from investigations into the human genome that current BAC BACs or PACs and have reasonably large transgene library-based shotgun protocols cannot achieve, as it is capacities, typically 300 kb, but have a maximum well documented that long inverted repeats, AT-rich potential of 700 kb. Other advantages include ease of sequences, are more stable in yeast than in E. coli.1,7 production and purification.2,5 Circular ACs require an However, as these vectors are produced in an organism origin of replication and an episomal maintenance that has minimal methyltransferase activity, this may element or a method of chromosome integration. In ultimately have implications in transgene expression in addition, if they are to be delivered by an infectious human beings, which have highly methylated DNA. agent, the appropriate packaging signal needs to be included in the plasmid. These requirements are often fulfilled by the use of viral elements. A new transposon-based technique for the generation of novel virus-based BACs Advances in the purification of YACs BAC and PAC vectors allow for quick, high yield, vector production (up to 500 mg DNA from 1 l culture). ACs can Production and purification of large size vectors such as be produced from BACs and PACs by the inclusion of YACs and HACs are problematic, not only because of episomal maintenance elements, usually of viral origin.2 low copy number vectors, which require purification In addition, the development of BAC technology has from large volumes of culture, but also because of the allowed the modification of large viral genomes to physical properties of the vector. become a viable tool for generating self-packaging AC A number of different protocols have recently been delivery vectors. A recent advance in the field of BAC developed, which provide methodologies for producing generation has used a sequence-independent in vitro YAC DNA, at concentrations typically 5–10 ng mlÀ1, and transposon-based methodology.9 This technique allows also reduces the likelihood of YAC sheering.1,6 One the construction of viral BACs through the use of a Tn5 successful protocol involves separating purified yeast transposition system. In brief, the authors constructed a chromosomes (including the YAC) through pulse-field linear vector using a plasmid containing the necessary gel electrophoresis. The YAC band is then excised from mini-F sequence required for BAC propagation in the agarose matrix, turned vertically and embedded in a bacteria, the chloramphenicol resistance gene, a GFP high percentage, low-melting point agarose. A second fluorescent marker and two Tn5 transposase recognition electrophoresis step concentrates the YACs into a single sequences. The linear construct is then incubated with point. The YAC spot can then be melted releasing the wild-type viral genome in vitro allowing random concentrated intact YACs, which can then be used for transposition to occur in the presence of a transposase. micro-injection. This methodology has proved successful The constructs are then propagated and screened using for producing YACs suitable for the transgenesis conventional BAC techniques. In vitro transposition of mice.6 alleviates the need for prior knowledge of the viral However, pulse-field gel electrophoresis can be time sequences, or the cloning of viral fragments, which may consuming and, therefore, a second YAC purification not be feasible in fastidious large-genome viruses. method has been developed for the purification of Importantly, this technique could be used to discover circular YACs containing genomic transcripts. This earlier unidentified viruses, which could be subse- technique uses transformation-associated recombination quently used as gene therapy vectors or ACs. (TAR) cloning and exonuclease chromatography purifi- cation.7,8 TAR cloning is based on co-transduction into yeast spheroplasts of isolated genomic DNA along with a Amplicon virus-like particles present 0 0 vector construct that contains 5 and 3 homologous efficient delivery mechanisms for ACs sequences specific for a gene of interest. Recombination between the vector and the target DNA establishes a Although viral-based BACs have the potential to fulfil YAC. This methodology allows entire genes and large the aforementioned criteria of ACs, they still have chromosomal regions to be isolated from total genomic limitations associated with immunogenicity, total nucleic DNA by in vitro recombination in yeast without the need acid capacity and, similar to all large constructs, to construct YAC or BAC libraries. In particular, the transduction efficacy. These limitations have led to the authors have shown that this technique is able to production and continued development of amplicon produce circular
Recommended publications
  • Recombinant DNA and Elements Utilizing Recombinant DNA Such As Plasmids and Viral Vectors, and the Application of Recombinant DNA Techniques in Molecular Biology

    Recombinant DNA and Elements Utilizing Recombinant DNA Such As Plasmids and Viral Vectors, and the Application of Recombinant DNA Techniques in Molecular Biology

    Fact Sheet Describing Recombinant DNA and Elements Utilizing Recombinant DNA Such as Plasmids and Viral Vectors, and the Application of Recombinant DNA Techniques in Molecular Biology Compiled and/or written by Amy B. Vento and David R. Gillum Office of Environmental Health and Safety University of New Hampshire June 3, 2002 Introduction Recombinant DNA (rDNA) has various definitions, ranging from very simple to strangely complex. The following are three examples of how recombinant DNA is defined: 1. A DNA molecule containing DNA originating from two or more sources. 2. DNA that has been artificially created. It is DNA from two or more sources that is incorporated into a single recombinant molecule. 3. According to the NIH guidelines, recombinant DNA are molecules constructed outside of living cells by joining natural or synthetic DNA segments to DNA molecules that can replicate in a living cell, or molecules that result from their replication. Description of rDNA Recombinant DNA, also known as in vitro recombination, is a technique involved in creating and purifying desired genes. Molecular cloning (i.e. gene cloning) involves creating recombinant DNA and introducing it into a host cell to be replicated. One of the basic strategies of molecular cloning is to move desired genes from a large, complex genome to a small, simple one. The process of in vitro recombination makes it possible to cut different strands of DNA, in vitro (outside the cell), with a restriction enzyme and join the DNA molecules together via complementary base pairing. Techniques Some of the molecular biology techniques utilized during recombinant DNA include: 1.
  • Gibson Assembly Cloning Guide, Second Edition

    Gibson Assembly Cloning Guide, Second Edition

    Gibson Assembly® CLONING GUIDE 2ND EDITION RESTRICTION DIGESTFREE, SEAMLESS CLONING Applications, tools, and protocols for the Gibson Assembly® method: • Single Insert • Multiple Inserts • Site-Directed Mutagenesis #DNAMYWAY sgidna.com/gibson-assembly Foreword Contents Foreword The Gibson Assembly method has been an integral part of our work at Synthetic Genomics, Inc. and the J. Craig Venter Institute (JCVI) for nearly a decade, enabling us to synthesize a complete bacterial genome in 2008, create the first synthetic cell in 2010, and generate a minimal bacterial genome in 2016. These studies form the framework for basic research in understanding the fundamental principles of cellular function and the precise function of essential genes. Additionally, synthetic cells can potentially be harnessed for commercial applications which could offer great benefits to society through the renewable and sustainable production of therapeutics, biofuels, and biobased textiles. In 2004, JCVI had embarked on a quest to synthesize genome-sized DNA and needed to develop the tools to make this possible. When I first learned that JCVI was attempting to create a synthetic cell, I truly understood the significance and reached out to Hamilton (Ham) Smith, who leads the Synthetic Biology Group at JCVI. I joined Ham’s team as a postdoctoral fellow and the development of Gibson Assembly began as I started investigating methods that would allow overlapping DNA fragments to be assembled toward the goal of generating genome- sized DNA. Over time, we had multiple methods in place for assembling DNA molecules by in vitro recombination, including the method that would later come to be known as Gibson Assembly.
  • A Comparative Look at High-Throughput Cloning Methods

    A Comparative Look at High-Throughput Cloning Methods

    Downloaded from genome.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press Review Many Paths to Many Clones: A Comparative Look at High-Throughput Cloning Methods Gerald Marsischky1 and Joshua LaBaer Institute of Proteomics, Harvard Medical School, Department of Biological Chemistry and Molecular Pharmacology, Boston, Massachusetts 02115, USA The creation of genome-scale clone resources is a difficult and costly process, making it essential to maximize the efficiency of each step of clone creation. In this review, we compare the available commercial and open-source recombinational cloning methods with regard to their use in creating comprehensive open reading frame (ORF) clone collections with an emphasis on the properties requisite to use in a high-throughput setting. The most efficient strategy to the creation of ORF clone resources is to build a master clone collection that serves as a quality validated source for producing collections of expression clones. We examine the methods for recombinational cloning available for both the creation of master clones and their conversion into expression clones. Alternative approaches to creating clones involving mixing of cloning methods, including gap-repair cloning, are also explored. Functional genomics and proteomics offer the promise of exam- sequence validated. Most importantly, once constructed, the ining the roles of all genes and proteins in an organism in a clones are effectively locked into the configuration of the original controlled format. These studies depend on the availability of vector. Moving the ORFs to a different vector would require start- cloned copies of the genes in a format conducive to protein ex- ing again at the PCR step, with its inherent incorporation errors pression.
  • Random-Sequence Genetic Oligomer Pools Display an Innate Potential For

    Random-Sequence Genetic Oligomer Pools Display an Innate Potential For

    RESEARCH ARTICLE Random-sequence genetic oligomer pools display an innate potential for ligation and recombination Hannes Mutschler1†‡*, Alexander I Taylor1†, Benjamin T Porebski1, Alice Lightowlers1§, Gillian Houlihan1, Mikhail Abramov2, Piet Herdewijn2, Philipp Holliger1* 1MRC Laboratory of Molecular Biology, Cambridge, United Kingdom; 2REGA Institute, Katholieke Universiteit Leuven, Leuven, Belgium Abstract Recombination, the exchange of information between different genetic polymer strands, is of fundamental importance in biology for genome maintenance and genetic diversification and is mediated by dedicated recombinase enzymes. Here, we describe an innate capacity for non-enzymatic recombination (and ligation) in random-sequence genetic oligomer pools. Specifically, we examine random and semi-random eicosamer (N20) pools of RNA, DNA and *For correspondence: the unnatural genetic polymers ANA (arabino-), HNA (hexitol-) and AtNA (altritol-nucleic acids). Correspondence to: ph1@mrc- While DNA, ANA and HNA pools proved inert, RNA (and to a lesser extent AtNA) pools displayed lmb.cam.ac.uk; [email protected] diverse modes of spontaneous intermolecular recombination, connecting recombination mechanistically to the vicinal ring cis-diol configuration shared by RNA and AtNA. Thus, the † These authors contributed chemical constitution that renders both susceptible to hydrolysis emerges as the fundamental equally to this work determinant of an innate capacity for recombination, which is shown to promote a concomitant Present address:
  • Cdna Libraries and Expression Libraries

    Cdna Libraries and Expression Libraries

    Solutions for Practice Problems for Recombinant DNA, Session 4: cDNA Libraries and Expression Libraries Question 1 In a hypothetical scenario you wake up one morning to your roommate exclaiming about her sudden hair growth. She has been supplementing her diet with a strange new fungus purchased at the local farmer’s market. You take samples of the fungus to your lab and you find that this fungus does indeed make a protein (the harE protein) that stimulates hair growth. You construct a fungal genomic DNA library in E. Coli with the hope of cloning the harE gene. If you succeed you will be a billionaire! You obtain DNA from the fungus, digest it with a restriction enzyme, and clone it into a vector. a) What features must be present on your plasmid that will allow you to use this as a cloning vector to make fungal genomic DNA library. Your vector would certainly need to have a unique restriction enzyme site, a selectable marker such as the ampicillin resistance gene, and a bacterial origin of replication. Other features may be required depending upon how you plan to use this library. b) You clone your digested genomic DNA into this vector. The E. coli (bacteria) cells that you will transform to create your library will have what phenotype prior to transformation? Prior to transformation, the E. coli cells that you will transform will be sensitive to antibiotic. This allows you to select for cells that obtained a plasmid. c) How do you distinguish bacterial cells that carry a vector from those that do not? Cells that obtained a vector will have obtained the selectable marker (one example is the ampicillin resistance gene).
  • Gene Cloningcloningcloning

    Gene Cloningcloningcloning

    GeneGeneGene CloningCloningCloning 20042004 SeungwookSeungwookKim Kim Chem.Chem. && Bio.Bio. Eng.Eng. Reference z T.A. Brown, Gene Cloning, Chapman and Hall z S.B. Primrose, Molecular Biotechnology, Blackwell 1 Why Gene Cloning is Important? z A century ago, Gregor Mendel : { Basic assumption (each heritable property of an organism) is controlled by a factor (gene). z In 1900, Mandel's law Æ the birth of genetics. z what these genes are and exactly how they work The Early Development of Genetics z In 1903, Sutton, W { Proposed that genes reside on chromosomes 2 z In 1910, Morgan, TH { Experimental backing on that --> development of the techniques for gene mapping (To establish the structure or structural details or location) { By 1922, a comprehensive analysis of the relative positions of over 2000 genes on the four chromosomes of the fruit fly. (Drosophilia melanogaster) z In 1944, Avery, MacLeod and McCarty z In 1952, Hershey and Chase { Experimental results were shown that DNA is the genetic material. { Conventional idea : genes were made of protein z In 1952-1966, Delbruck, Chargaff, Crick and Monod { The structure of DNA was elucidated. { The genetic code was cracked. { The process of transcription and translation were described. 3 The Advent of Gene Cloning z In the late 1960's ; The experimental techniques were not sophisticated. z In 1971 ~ 1973 ; A new experimental techniques were developed. { Recombinant DNA technology or Genetic engineering based on the process of gene cloning { This led to rapid and efficient DNA sequencing techniques that enabled the structures of individual genes to be determined. z In the 1990s ; started with massive genome sequencing projects including the human project.
  • 10. E. Coli Cloning Vector Pbr322

    10. E. Coli Cloning Vector Pbr322

    10. E. coli cloning vector pBR322 Important questions based on it: A. (a) Name the organism in which the vector shown is inserted to get the copies of the desired gene. (b) Mention the area labelled in the vector responsible for controlling the copy number of the inserted gene. (c) Name and explain the role of a selectable marker in the vector shown. (AI 2010) B. (a) Identify the selectable markers in the diagram of E. coli vector shown below. (b) How is the coding sequence of -galactosidase considered a better marker than the ones identified by you in the diagram? Explain. (Delhi 2009) A. Explain the importance of (a) ori, (b) ampR and (c) rop in the E. coli vector shown below. (AI 2008) B. Draw pBR322 cloning vector. Label ‘ori’, ‘rop’ and any one antibiotic resistance site on it and state their functions. (AI 2015C) C. Draw a schematic diagram of the E. coli cloning vector pBR322 and mark the following in it: (a) ori (b) rop (c) ampicillin resistance gene (d) tetracycline resistance gene (e) restriction site BamHI (f) restriction site EcoR I (AI 2014C) D. Draw a schematic sketch of pBR322 plasmid and label the following in it: (a) Any two restriction sites. (b) Ori and rop genes. (c) An antibiotic resistant gene. (Delhi 2012) E. Identify A, B, C and D in the given diagram. (a) A-ori, B-ampR, C-tetR, D-HindIII (b) A-HindIII, B-tetR, C-ampR, D-ori (c) A-ampR, B-tetR, C-HindIII, D-ori (d) A-tetR, B-HindIII, C-ori, D-ampR (COMEDK) F.
  • Large-Insert BAC/YAC Libraries for Selective Re-Isolation of Genomic Regions by Homologous Recombination in Yeast

    Large-Insert BAC/YAC Libraries for Selective Re-Isolation of Genomic Regions by Homologous Recombination in Yeast

    doi:10.1006/geno.2001.6616, available online at http://www.idealibrary.com on IDEAL Article Large-Insert BAC/YAC Libraries for Selective Re-isolation of Genomic Regions by Homologous Recombination in Yeast Changjiang Zeng,1,5 Natalay Kouprina,2 Baoli Zhu,1,5 Al Cairo,1 Maarten Hoek,3 George Cross,3 Kazutoyo Osoegawa,1,5 Vladimir Larionov,2 and Pieter de Jong1,5,* 1Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York 14263, USA 2Laboratory of Biosystems and Cancer, National Cancer Institute, Bethesda, Maryland 20892, USA 3Laboratory of Molecular Parasitology, Rockefeller University, New York, New York 10021, USA 4Present address: Exelixis, South San Francisco, California 94080, USA 5Present address: Children’s Hospital Oakland, BACPAC Resources, 747-52nd Street, Oakland, California 94609, USA *To whom correspondence and reprint requests should be addressed. Fax: (510) 749-4266. E-mail: [email protected]. We constructed representative large-insert bacterial artificial chromosome (BAC) libraries of two human pathogens (Trypanosoma brucei and Giardia lamblia) using a new hybrid vector, pTARBAC1, containing a yeast artificial chromosome (YAC) cassette (a yeast selectable marker and a centromere). The cassette allows transferring of BACs into yeast for their fur- ther modification. Furthermore, the new hybrid vector provides the opportunity to re-isolate each DNA insert without construction of a new library of random clones. Digestion of a BAC DNA by an endonuclease that has no recognition site in the vector, but which deletes most of the internal insert sequence and leaves the unique flanking sequences, converts a BAC into a TAR vector, thus allowing direct gene isolation.
  • Molecular Cloning Plasmid-Based Cloning Vectors

    Molecular Cloning Plasmid-Based Cloning Vectors

    Page: 1 Molecular Cloning A glaring problem in most areas of biochemical research is obtaining sufficient amounts of the substance of interest. For example, a 10 L culture of E. coli grown to its maximum titer will only contain about 7 mg of DNA polymerase I, and many other proteins in much lesser amounts. Furthermore, only rarely can as much as half of any protein originally present in an organism be recovered in pure form. Eucaryotic proteins are even more difficult to obtain because tissue samples are usually only available in small quantities. With regards to the amount of DNA present, the 10 L E. coli culture would contain about 0.1mg of any 1000 bp length chromosomal DNA but its purification in the presence of the rest of the chromosomal DNA would be a very difficult task. These difficulties have been greatly reduced through the development of molecular cloning techniques. These methods, which are also referred to as genetic engineering and recombinant DNA technology, deserve much of the credit for the enormous progress in biochemistry and the dramatic rise of the biotechnology industry. The main idea of molecular cloning is to insert a DNA segment of interest into an autonomously replicating DNA molecule, a so-called cloning vector, so that the DNA segment is replicated with the vector. Cloning such a chimeric vector in a suitable host organism such as E. coli or yeast results in the production of large amounts of the inserted DNA segment. If a cloned gene is flanked by the properly positioned control sequences for RNA and protein synthesis, the host may also produce large quantities of the mRNA and protein specified by that gene.
  • High-Throughput Cloning and Characterization of Emerging Adenovirus Types 70, 73, 74, and 75

    High-Throughput Cloning and Characterization of Emerging Adenovirus Types 70, 73, 74, and 75

    International Journal of Molecular Sciences Article High-Throughput Cloning and Characterization of Emerging Adenovirus Types 70, 73, 74, and 75 Wenli Zhang 1, Kemal Mese 1, Sebastian Schellhorn 1 , Nora Bahlmann 1, Nicolas Mach 1, Oskar Bunz 1 , Akshay Dhingra 2, Elias Hage 2, Marie-Edith Lafon 3, Harald Wodrich 3 , Albert Heim 2 and Anja Ehrhardt 1,* 1 Virology and Microbiology, Center for Biomedical Education and Research (ZBAF), Department of Human Medicine, Faculty of Health, Witten/Herdecke University, 58453 Witten, Germany; [email protected] (W.Z.); [email protected] (K.M.); [email protected] (S.S.); [email protected] (N.B.); [email protected] (N.M.); [email protected] (O.B.) 2 Institut für Virologie, Adenovirus Konsiliarlabor, Medizinische Hochschule, 30625 Hannover, Germany; [email protected] (A.D.); [email protected] (E.H.); [email protected] (A.H.) 3 Microbiologie Fondamentale et Pathogénicité, Université de Bordeaux, 33076 Bordeaux, France; [email protected] (M.-E.L.); [email protected] (H.W.) * Correspondence: [email protected]; Tel.: +49-2302-926273 Received: 31 July 2020; Accepted: 31 August 2020; Published: 2 September 2020 Abstract: Recently an increasing number of new adenovirus types associated with type-dependent pathogenicity have been identified. However, identification of these clinical isolates represents the very first step to characterize novel pathogens. For deeper analyses, these adenoviruses need to be further characterized in basic virology experiments or they could be applied in translational research. To achieve this goal, it is essential to get genetic access and to enable genetic modification of these novel adenovirus genomes (deletion, insertion, and mutation).
  • In Vitro Replication of Recombinant Plasmids Carryingchromosomal

    In Vitro Replication of Recombinant Plasmids Carryingchromosomal

    Proc. Nati Acad. Sci. USA Vol. 79, pp. 3697-3701, June 1982 Biochemistry In vitro replication of recombinant plasmids carrying chromosomal segments of Xenopus laevis (eukaryotic DNA/replication origins/DNA initiation/cloning/electron microscopy) SOTA HIRAGA*, TADASHI SUDO*, MASARU YOSHIDA*t, HIROSHI KUBOTAt, AND HISAO UEYAMA§ *Institute for Virus Research, Kyoto University, Kyoto 606, Japan; *Department of Sciences, Kyoto University, Kyoto 606, Japan; and §Department of Medical Biochemistry, Shiga University of Medical Science, Seta Ohtsu 520-21, Japan Communicated by J. Herbert Taylor, March 11, 1982 ABSTRACT Recombinant plasmids carrying a segment of consisted of the vector pMB9 and a segment that coded for Xenopus laevis chromosomal DNA were constructed with plasmid rRNA in X. laevis. pBR322 as the vector. A recombinant plasmid pXY65 carrying a In this paper, we describe a recombinant plasmid carrying 3.2-kilobase BamHI segment of the chromosome of X. laevis has a chromosomal segment ofX. laevis which initiates replication been found to contain a repetitive sequence dispersed throughout in vitro in an extract prepared from unfertilized eggs ofX. laevis the X. laevis chromosomes. This plasmid initiated replication in according to the procedure of Benbow etal. (15). The replication vitro when the supercoiled circular molecules were incubated in was initiated at a specific site on the Xenopus segment and a replication system. The other recombinant plasmids tested and usually proceeded bidirectionally. the pBR322 vector were not replicated. Electron microscopic analysis of the replicative intermediates showed that the replica- MATERIALS AND METHODS tion was initiated at a specific site in the 3.2-kilobase BamHI seg- Bacterial Strain and Vector Plasmid.
  • Chapter 13 an Introduction to Cloning and Recombinant DNA Clones

    Chapter 13 an Introduction to Cloning and Recombinant DNA Clones

    Chapter 13 An Introduction to Cloning and Recombinant DNA Clones • Genetically identical organisms or molecules derived from a common ancestor Cloning Plants from Single Cells Fig. 13.1 Cloning Animals • Animals were cloned more than 20 years ago • Two techniques – Embryo splitting – Nuclear transfer animalscience.ucdavis.edu library.thinkquest.org Embryo Splitting • Egg collected • Fertilized by in vitro fertilization (IVF) • Embryo is grown to 8–16 cells • Cells are separated • Separated cells grown into separate embryos • Embryos transplanted into surrogate mothers • May be used to clone any mammalian embryos, including humans Cloning by nuclear transfer www.biotechnologyonline.gov.au Cloning by nuclear transfer www.pnas.org Nuclear Transfer • First done in 1986 • More difficult • Nucleus is removed from an egg • Enucleated eggs are fused with other cells • Embryos are transplanted into a surrogate mother • In 1997, Dolly the sheep was the first mammalian clone from an adult donor cell Cloned animals Second addition Second chance Also cloned animals about to go extinct - gaur etc at Texas A&M Fig. 13.5 Cloning Mice by Injection of Nuclei from Adult Cells Problems - don’t live as long not carbon copies/identical develop diseases early very low success rate - 0.1 - 3% Dedifferentiation/reprogramming may not be complete or accurate Gene Cloning GOAL: To get enough copies of the gene to manipulate Gene Cloning vector Recombinant DNA Host Multiply Started with: few copies Ended with: Many copies. All identical to starting gene - CLONES Restriction enzymes Nobel Prize Werner Arber, Daniel Nathans and Hamilton O. Smith 1978 Restriction Enzymes Fig. 13.6 Inserting foreign DNA using restriction enzymes Ligase BamHI BamHI GGATCC GGATCC CCTAG G CCTAG G GATCC G G CCTAG Frequency of occurrence of restriction sites If DNA sequence has equal amounts of each base If bases are distributed randomly 6 base cutter (1/4)6 = 1 site in ~4000 bp 4 base cutter (1/4)4 = 1 site in 256 bp Common Restriction Enzymes Fig.